About AEI My AEI Support AEI Contact AEI
Home Events Books Short Publications Research Areas Scholars & Fellows


Search


FindAdvanced Search

Browse all books by:
- Date
- Subject
- Author
- Title

BOOKS
About the AEI Press
Orders and Shipping
Book Reviews
Press Releases

AEI Classics

AEI is rereleasing some of its most prescient and groundbreaking works from its earliest thinkers and innovators. These books, part of a series called AEI Classics, are available for download as Adobe Acrobat PDFs.

E-NEWSLETTERS
Enter e-mail:
 

Home >  Books >  Private Discounts, Public Subsidies
Private Discounts, Public Subsidies
Print Mail
How the Medicare Prescription Drug Discount Card Really Works
By Joseph Antos, Ximena Pinell
Posted: Wednesday, June 16, 2004
Private Discounts, Public Subsidies
Dimensions: 8.5'' x 11''
44 pages
AEI Press  (Washington)
Publication Date: June 2004
Paperback
ISBN: 0-8447-7180-5
Price: $ 10.00
Add to Cart  
Examination Copies

Download file The full text of this study is available in Adobe Acrobat PDF format.

Critics wasted no time in pronouncing the Medicare prescription drug discount card program a failure. The evidence, however, proves otherwise.

The new Medicare discount card program can help millions of seniors and disabled people save money on their prescriptions. Prices available through Medicare-approved cards are 5–50 percent lower than prices offered by well-known discounters, including AARP, Costco, and drugstore.com.

The neediest seniors stand to save even more. For them, discounts negotiated by the card sponsors are only part of the story. Low-income seniors without other drug coverage also receive a $600 taxpayer subsidy and special discounts made available by pharmaceutical manufacturers. Between June and December 2004, these beneficiaries could save between one half and three quarters of their prescription cost through this public-private partnership.

Despite the potentially large savings available through Medicare discount cards, initial enrollment was disappointing. That might have been expected: Seniors are unfamiliar with this novel program, and a storm of bad press may have discouraged some seniors from looking into it. This study documents the need for better consumer information, particularly on special discounts offered by pharmaceutical companies that can provide very generous savings to many low-income beneficiaries. The failure to make that information transparent and easy to access must be overcome if this program is to live up to its full potential.

Joseph Antos is the Wilson H. Taylor Scholar in Health Care and Retirement Policy at the American Enterprise Institute and an adjunct professor in the School of Public Health at the University of North Carolina at Chapel Hill.

Ximena Pinell is a research assistant at the American Enterprise Institute. Her work includes a variety of projects on health system reform.



Table of Contents

Acknowledgments

Introduction

  • Origins of the Discount Card Program
  • Plan of the Study

Discount and Assistance Programs Available Outside of Medicare

  • Discount Programs Sponsored by Organizations Other than Pharmaceutical Manufacturers
  • Senior Discount Card Programs Sponsored by Pharmaceutical Manufacturers
  • Patient Assistance Programs Sponsored by Pharmaceutical Manufacturers
  • State Pharmacy Assistance Programs

The Medicare Prescription Drug Discount Card Program

  • Medicare Drug Discount Cards
  • Transitional Cash Assistance

Finding the Best Deal

  •  Three Typical Beneficiaries
  •  Choosing the Right Medicare Discount Card

Prospects for Success

  •  Encouraging Enrollment
  •  Competition vs. Regulation
  •  Catalyst for Change

Appendix
Notes

Available in Adobe Acrobat PDF format.
Related Links
Press release
Related event
Health Policy Studies at AEI
Coverage in the AEI Newsletter


Also by Joseph Antos
Recent Articles
Saving Medicare
Health Reform and the Presidential Candidates
Lessons from the Clinton Plan
Latest Book
Restoring Fiscal Sanity 2007
The Health Spending Challenge
Cuba the Morning After
Cuba the Morning After

What lies ahead for Cuba after Castro? Mark Falcoff writes that an economically unviable and otherwise dysfunctional Cuba could in coming years pose an even bigger threat to the United States than in its communist heyday.


Air Quality in America
Air Quality in America

This detailed, data-driven book rebuts mistaken perceptions that U.S. air quality is bad by documenting marked improvements over the past decades.


Europe's Coming Demographic Challenge- thumbnail
Europe's Coming Demographic Challenge

The promise of "healthy aging" offers significant opportunities for economic growth and development for Europe in the decades ahead--if governments and citizens are willing to grasp them.